British team announces ‘major breakthrough’ in Covid-19 treatment – dpa international

At the entrance to a restaurant in Kuala Lumpur. Face masks are widely-used in some countries as a preventive measure against the novel coronavirus - a disease for which there is no vaccine (Simon Roughneen)

DUBLIN — A steroid called dexamethasone should be given to patients affected by Covid-19, the disease caused by the new coronavirus, British researchers reported on Tuesday. Tests on 2,104 patients showed that low doses of the drug cut deaths by a third among patients on ventilators and by a fifth among those receiving oxygen, findings described by the researchers as a “major breakthrough” that “will save lives.” “One death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” said the research team, which is testing a range of drugs on 11,500 Covid-19 patients at 175 British hospitals/ Martin Landray of the University of Oxford, one of the trial’s leaders, said that dexamethasone, a drug in use since the 1960s to treat inflammations and conditions such as asthma, could prove a “remarkably low cost” means of combatting the coronavirus pandemic.